You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 129 No. 7, July 1975 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (81)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment of Laryngotracheobronchitis (Croup)

Use of Intermittent Positive-Pressure Breathing and Racemic Epinephrine

Lynn M. Taussig, MD; Oscar Castro, MD; Pierre H. Beaudry, MD; William W. Fox, MD; Michel Bureau, MD

Am J Dis Child. 1975;129(7):790-793.


Abstract



Use of racemic epinephrine hydrochloride (Vaponefrin), delivered by intermittent positive-pressure breathing, in the treatment of laryngotracheobronchitis (croup) produced acute beneficial results in a controlled study. However, symptoms often recurred within two hours, suggesting that this form of treatment should not be used in the emergency room and the patient then sent home. This treatment had no effect on arterial oxygen gas pressure. The changes in clinical status 24 to 36 hours after admission into the study were similar for the patients in the treatment and control groups, suggesting that the natural history of the disease was not drastically altered by this form of treatment.



Author Affiliations



From the Respiratory Function Department, Montreal Children's Hospital, McGill University. Dr. Taussig was a fellow of the Cystic Fibrosis Foundation and is now with the Arizona Medical Center, Tucson.


Footnotes



Received for publication Aug 21, 1974; accepted Oct 21.

Reprint requests to Department of Pediatrics, Arizona Medical Center, Tucson, AZ 85724 (Dr. Taussig).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Medicines used in respiratory diseases only seen in children
Lenney et al.
Eur Respir J 2009;34:531-551.
ABSTRACT | FULL TEXT  

Use of helium-oxygen mixtures in the treatment of croup: a systematic review
Vorwerk and Coats
Emerg. Med. J. 2008;25:547-550.
ABSTRACT | FULL TEXT  

The management of croup
Brown
Br Med Bull 2002;61:189-202.
ABSTRACT | FULL TEXT  

Telemedicine in Pediatric Transport: A Feasibility Study
Kofos et al.
Pediatrics 1998;102:e58-e58.
ABSTRACT | FULL TEXT  

Inhaled budesonide and adrenaline for croup
DTB 1996;34:23-24.
ABSTRACT | FULL TEXT  

Interobserver Variability in Assessing Pediatric Postextubation Stridor
Kemper et al.
CLIN PEDIATR 1992;31:405-408.
ABSTRACT  

The Old and New of Acute Laryngotracheal Infections
Cunningham
CLIN PEDIATR 1992;31:56-64.
ABSTRACT  

Pediatric Aerosol Therapy Guidelines: Indications, Techniques, and Dosages
Alderson and Warren
CLIN PEDIATR 1984;23:553-557.
ABSTRACT  

The Usefulness of Lateral Neck Roentgenograms in Laryngotracheobronchitis
Mills et al.
Arch Pediatr Adolesc Med 1979;133:1140-1142.
ABSTRACT  

Nebulized Racemic Epinephrine by IPPB for the Treatment of Croup: A Double-Blind Study
Westley et al.
Arch Pediatr Adolesc Med 1978;132:484-487.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1975 American Medical Association. All Rights Reserved.